FOLH1 and posterior cortical atrophy: In a systematic review with a meta-analysis by Jeet et al., 54 studies were summarized, revealing that PSMA-PET/CT ([68Ga]Ga-PSMA-11 in 81% and [18F]-PSMA in 13% of the studies) led to changes in clinical management in 28% of the cases with primary PCa and in 54% of the cases with recurrent disease [15].